Cerus vs SI-BONE
Cerus reported revenue of $234 million in fiscal 2025, 1.2 times SI-BONE's $201 million in fiscal 2025. Cerus' revenue grew 16.1% in its latest year, and SI-BONE's grew 20.2%. Cerus had an operating margin of -3.7%, against -11.1% at SI-BONE. Free cash flow was $1 million at Cerus and −$9 million at SI-BONE.
Side by side
| Cerus | SI-BONE | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $234M | $201M |
| Revenue growth | 16.1% | 20.2% |
| Revenue growth a year, last 5 years | 15.4% | 22.3% |
| Gross margin | — | 79.6% |
| Operating margin | −3.7% | −11.1% |
| Net margin | −6.7% | −9.4% |
| Free cash flow | $1M | −$9M |
| Free cash flow margin | 0.5% | −4.5% |
| Return on capital | — | −26.3% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 3.3% | 3.6% |
| Last close | $1.99 | $23.44 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | — | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CerusSI-BONE
Operating margin
Percent of revenue
CerusSI-BONE
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CerusSI-BONE